237 related articles for article (PubMed ID: 21795478)
1. Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer.
Hu W; Lu C; Dong HH; Huang J; Shen DY; Stone RL; Nick AM; Shahzad MM; Mora E; Jennings NB; Lee SJ; Roh JW; Matsuo K; Nishimura M; Goodman BW; Jaffe RB; Langley RR; Deavers MT; Lopez-Berestein G; Coleman RL; Sood AK
Cancer Res; 2011 Sep; 71(18):6030-9. PubMed ID: 21795478
[TBL] [Abstract][Full Text] [Related]
2. The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study.
Zhang JF; Chen Y; Qiu XX; Tang WL; Zhang JD; Huang JH; Lin GS; Wang XF; Lin ZX
Tumour Biol; 2016 Mar; 37(3):3797-805. PubMed ID: 26472724
[TBL] [Abstract][Full Text] [Related]
3. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
[TBL] [Abstract][Full Text] [Related]
4. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived endothelial progenitors expressing Delta-like 4 (Dll4) regulate tumor angiogenesis.
Real C; Remédio L; Caiado F; Igreja C; Borges C; Trindade A; Pinto-do-Ó P; Yagita H; Duarte A; Dias S
PLoS One; 2011 Apr; 6(4):e18323. PubMed ID: 21483741
[TBL] [Abstract][Full Text] [Related]
6. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.
Jubb AM; Turley H; Moeller HC; Steers G; Han C; Li JL; Leek R; Tan EY; Singh B; Mortensen NJ; Noguera-Troise I; Pezzella F; Gatter KC; Thurston G; Fox SB; Harris AL
Br J Cancer; 2009 Nov; 101(10):1749-57. PubMed ID: 19844231
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between leukemic and endothelial cells promotes angiogenesis by VEGF activation of the Notch/Dll4 pathway.
Zhang J; Ye J; Ma D; Liu N; Wu H; Yu S; Sun X; Tse W; Ji C
Carcinogenesis; 2013 Mar; 34(3):667-77. PubMed ID: 23239744
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.
Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL
Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.
Yu S; Sun J; Zhang J; Xu X; Li H; Shan B; Tian T; Wang H; Ma D; Ji C
Histol Histopathol; 2013 Feb; 28(2):277-84. PubMed ID: 23275310
[TBL] [Abstract][Full Text] [Related]
10. The expression of VEGF and Dll4/Notch pathway molecules in ovarian cancer.
Wang H; Huang X; Zhang J; Shao N; Chen LO; Ma D; Ji C
Clin Chim Acta; 2014 Sep; 436():243-8. PubMed ID: 24949865
[TBL] [Abstract][Full Text] [Related]
11. Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade.
Yamanda S; Ebihara S; Asada M; Okazaki T; Niu K; Ebihara T; Koyanagi A; Yamaguchi N; Yagita H; Arai H
Blood; 2009 Apr; 113(15):3631-9. PubMed ID: 19218547
[TBL] [Abstract][Full Text] [Related]
12. Influence of Dll4 via HIF-1α-VEGF signaling on the angiogenesis of choroidal neovascularization under hypoxic conditions.
Dong X; Wang YS; Dou GR; Hou HY; Shi YY; Zhang R; Ma K; Wu L; Yao LB; Cai Y; Zhang J
PLoS One; 2011 Apr; 6(4):e18481. PubMed ID: 21526177
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.
Williams CK; Li JL; Murga M; Harris AL; Tosato G
Blood; 2006 Feb; 107(3):931-9. PubMed ID: 16219802
[TBL] [Abstract][Full Text] [Related]
14. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
[TBL] [Abstract][Full Text] [Related]
15. Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth.
Huang J; Hu W; Hu L; Previs RA; Dalton HJ; Yang XY; Sun Y; McGuire M; Rupaimoole R; Nagaraja AS; Kang Y; Liu T; Nick AM; Jennings NB; Coleman RL; Jaffe RB; Sood AK
Mol Cancer Ther; 2016 Jun; 15(6):1344-52. PubMed ID: 27009216
[TBL] [Abstract][Full Text] [Related]
16. Delta-like 4/Notch signaling promotes Apc
Badenes M; Trindade A; Pissarra H; Lopes-da-Costa L; Duarte A
BMC Cancer; 2017 Jan; 17(1):50. PubMed ID: 28086833
[TBL] [Abstract][Full Text] [Related]
17. Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling.
Benedito R; Rocha SF; Woeste M; Zamykal M; Radtke F; Casanovas O; Duarte A; Pytowski B; Adams RH
Nature; 2012 Mar; 484(7392):110-4. PubMed ID: 22426001
[TBL] [Abstract][Full Text] [Related]
18. Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells.
Williams CK; Segarra M; Sierra Mde L; Sainson RC; Tosato G; Harris AL
Cancer Res; 2008 Mar; 68(6):1889-95. PubMed ID: 18339870
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.
Kim DH; Lee S; Kang HG; Park HW; Lee HW; Kim D; Yoem DH; Ahn JH; Ha E; You WK; Lee SH; Kim SJ; Chun KH
BMB Rep; 2020 Nov; 53(10):533-538. PubMed ID: 32580836
[TBL] [Abstract][Full Text] [Related]
20. Effect of DLL4 siRNA on proliferation, migration and tube formation of choroid-retinal endothelial cells under hypoxic conditions.
He H; Li B; Zhang H; Xiang N; Li GG
Chin Med J (Engl); 2011 Jan; 124(1):118-26. PubMed ID: 21362319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
